Compare NBTX & WLFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NBTX | WLFC |
|---|---|---|
| Founded | 2003 | 1985 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2018 | 1997 |
| Metric | NBTX | WLFC |
|---|---|---|
| Price | $31.04 | $174.66 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $36.00 | N/A |
| AVG Volume (30 Days) | ★ 48.5K | 45.7K |
| Earning Date | 03-31-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.91% |
| EPS Growth | N/A | ★ 146.23 |
| EPS | N/A | ★ 13.89 |
| Revenue | N/A | ★ $569,223,000.00 |
| Revenue This Year | $60.67 | N/A |
| Revenue Next Year | N/A | $10.42 |
| P/E Ratio | ★ N/A | $12.61 |
| Revenue Growth | N/A | ★ 36.00 |
| 52 Week Low | $2.99 | $114.01 |
| 52 Week High | $41.89 | $207.05 |
| Indicator | NBTX | WLFC |
|---|---|---|
| Relative Strength Index (RSI) | 50.89 | 49.55 |
| Support Level | $20.11 | $130.26 |
| Resistance Level | $41.89 | $185.85 |
| Average True Range (ATR) | 1.72 | 6.76 |
| MACD | -0.29 | 0.69 |
| Stochastic Oscillator | 41.82 | 68.58 |
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
Willis Lease Finance Corp, with its subsidiaries, is a lessor and servicer of commercial aircraft and aircraft engines. The company has two reportable business segments, which include Leasing and Related Operations and Spare Parts Sales. A majority of its revenue is generated from the Leasing and Related Operations segment, which involves acquiring and leasing, under operating leases, commercial aircraft, aircraft engines, and other aircraft equipment and the selective purchase and resale of commercial aircraft engines, aircraft equipment, and other related businesses. Geographically, the company derives maximum Lease rent revenue from the United States, followed by Europe, Asia-Pacific (excluding India), India, South America, Canada, Central America, and the Middle East.